Sunitinib for the Treatment of Gastrointestinal Stromal Tumours: A Critique of the Submission From Pfizer

Health Technology Assessment - United Kingdom
doi 10.3310/hta13suppl2/10
Full Text
Abstract

Available in full text

Date
Authors
Publisher

National Institute for Health Research

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy